Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
about
Association between serum interleukin-6 concentration and mortality in patients with coronary artery diseaseUrinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul StudyAggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomesAnalysis of the urinary peptidome associated with Helicobacter pylori infection.Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: findings from the Heart and Soul Study.The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart diseaseGenetic and environmental influences on the prospective correlation between systemic inflammation and coronary heart disease death in male twins.Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul studyAssociation between serum C-peptide as a risk factor for cardiovascular disease and high-density lipoprotein cholesterol levels in nondiabetic individuals.NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus StudyThe Difference Quantity of Urinary Peptides between Two Groups of Type 2 Diabetic Patients with or without Coronary Artery DiseaseCystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.Post-traumatic stress disorder is associated with poor health behaviors: findings from the heart and soul study.The acute phase inflammatory response to maximal exercise testing in children and young adults with sickle cell anaemia.Metabolic biomarkers for predicting cardiovascular disease.Elevated Levels of Serum Fibrin and Fibrinogen Degradation Products Are Independent Predictors of Larger Coronary Plaques and Greater Plaque Necrotic Core.The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjectsSignificance of Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy in Patients Undergoing Coronary AngiographyCystatin C, other markers of kidney disease, and incidence of age-related cataract.Biomarkers of atherosclerosis: clinical applicationsThe involvement of multiple thrombogenic and atherogenic markers in premature coronary artery disease.Interruption of antiretroviral therapy is associated with increased plasma cystatin CUsefulness of NT-proBNP in the Follow-Up of Patients after Myocardial Infarction.Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target.Microfluidic strategies applied to biomarker discovery and validation for multivariate diagnostics.Acute coronary syndrome and depression: A review of shared pathophysiological pathways.Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death.A dual-label time-resolved fluorescence immunoassay for the simultaneous determination of cystatin C and β2-microglobulin in urine.Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care.Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.An Aggregate Biomarker Risk Score Predicts High Risk of Near-Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes).Plasminogen and fibrinogen plasma levels in coronary artery diseaseImpact of contrast-induced nephropathy and cardiovascular events by serum cystatin C in renal insufficiency patients undergoing cardiac catheterization.Lifestyle factors as predictors of general cardiovascular disease: use for early self-screening.High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery diseaseHigh-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial
P2860
Q27023903-A9F7CD8C-0C92-4505-89B7-899CFED60834Q33749342-0EFB1FA7-3F7F-4EB1-8819-5FD0E615F97CQ33791968-6EBFB189-5618-4F2D-9D54-CA2953439947Q33829666-B766DB02-3380-4C8E-AF86-F623B3DD5E6FQ33842504-AF752EE1-221C-4769-898B-D281FAADD228Q34033670-6A71469D-765E-4EC1-8A2F-E34BE264D267Q34180517-168AAC81-747C-4984-B880-B72C0AB7E333Q34308313-DDB0C8C8-B497-4933-9C7E-49DE03DE7B74Q34822621-AF1D8693-1113-4647-ACF7-B2F3239A2FB7Q35054042-3A9B7210-02DC-4833-9497-5C7DF55FFC85Q35672431-328DD7E0-F9CC-4714-AE06-CC94190943E5Q35746107-810A1646-AAC9-4A57-B6DC-701F72A109A2Q35809606-89D2E3DC-EEE0-42C8-BCA0-53A165A96014Q36470656-1CD66271-8620-4FA8-81B9-2A60216695A3Q36584772-010EFA3E-BEEA-4ABB-8A88-769E8619F604Q36872650-FE05EE61-D4B2-443F-B687-148B856ECCBBQ37163361-6389D014-285D-4FE1-8514-CE32FDBE15A8Q37217566-90976802-108A-42C1-8DE5-A5F19C024813Q37301522-CFE477F3-200F-4451-96A9-2F3D3BA7542DQ37307999-06C08F8C-02EC-4885-A20B-B5F67D476AA9Q37342485-43232351-3AC0-485A-9A50-E18BA0D5F0B7Q37386153-949E0270-30F7-48D1-B178-32CC5120BA1AQ37694917-172122AB-8F1A-4AA5-AC7A-36EBCD48DCB6Q37878492-F1A931F2-6C28-4FD0-96C4-067722C37514Q37943855-AEBEA2FE-2908-45DA-895F-A73767A23387Q38556216-C12E1F8D-BA2C-465B-B1A1-D7B90DE8C261Q38747883-8BB4B0B2-C202-465D-86DD-C170E2436A3AQ39185168-57A0B0B3-BF4B-413A-A2B1-15ABD6697495Q39874478-E2D321EF-58A0-48FD-A40D-BCE79CDC86A5Q41140893-76047F9A-B4D2-4228-B4FB-ED814217CAF7Q41627043-B5CE08BF-DD2F-4FFB-B7A9-9F8CAADC3D0FQ41835845-0FE5306F-A2B6-4E24-91A3-99D1E51F5909Q42858592-492DD932-7DDC-47C7-98E6-10103A7864BAQ48270246-BD7424C7-BB90-4274-8AD2-A586726BF438Q51778180-4012BFC4-0EFB-4112-ABC6-71A794019557Q57389513-626083F6-C988-4220-8B30-F4D6DE4F8C18Q57389527-36D236A8-BB62-4A67-8FFF-C39057DEFA49
P2860
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
@ast
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
@en
type
label
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
@ast
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
@en
prefLabel
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
@ast
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
@en
P2860
P50
P1476
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
@en
P2093
P2860
P356
10.1016/J.AMJMED.2007.06.030
P407
P577
2008-01-01T00:00:00Z